Amanote Research
Register
Sign In
Should Genetic Information Be Disclosed to Insurers? Yes
BMJ
doi 10.1136/bmj.39216.468495.ad
Full Text
Open PDF
Abstract
Available in
full text
Date
June 7, 2007
Authors
Søren Holm
Publisher
BMJ
Related search
Should Life Insurers Have Access to Genetic Test Results?
JAMA - Journal of the American Medical Association
Medicine
Should Red Cell Transfusion Be Individualized? Yes
Intensive Care Medicine
Critical Care
Intensive Care Medicine
Should Cost Considerations Be Included in Medical Decisions? Yes
Intensive Care Medicine
Critical Care
Intensive Care Medicine
Unruptured Brain Arteriovenous Malformations Should Be Treated Conservatively: Yes
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Should Women Be Offered Cholesterol Lowering Drugs to Prevent Cardiovascular Disease? Yes
BMJ
Rescue Therapy for Refractory ARDS Should Be Offered Early: Yes
Intensive Care Medicine
Critical Care
Intensive Care Medicine
What Advice Should Be Given to People With Epilepsy – Physical Activity, Yes or No?
Facta Universitatis Series Physical Education and Sport
Orthopedics
Sports Medicine
POINT: Should Molecular and Genetic Biomarkers Be Used in the Initial Evaluation of Patients With Fibrotic ILD? Yes
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Should Patients Be Able to Pay Top-Up Fees to Receive the Treatment They Want? Yes
BMJ